Modulation of oestrogen action by receptor gene inhibition

T A Madden1, D Barrow, R A McClelland

  • 1Tenovus Cancer Research Centre, Welsh School of Pharmacy, Redwood Building, King Edward VII Ave, CF10 3XE, Cardiff, UK. maddenta1@cardiff.ac.uk

European Journal of Cancer (Oxford, England : 1990)
|November 1, 2000
PubMed

Insights

Novel molecular strategies, including antisense RNA and dominant-negative mutants, effectively reduce estrogen receptor (ER) levels. These selective estrogen receptor downregulators (SERDs) show promise for cancer therapy by targeting ER expression and activity.

Area of Science:

  • Molecular biology
  • Cancer research
  • Pharmacology

Background:

  • Selective estrogen receptor downregulators (SERDs) are crucial for reducing cellular estrogen receptor (ER) levels.
  • Estrogen receptor (ER) signaling plays a significant role in various cancers.

Purpose of the Study:

  • To compare the efficacy of three novel molecular approaches as SERDs: antisense oligonucleotides, antisense RNA, and dominant-negative mutants.
  • To evaluate the in vitro effectiveness of these agents in downregulating ER expression and activity.

Main Methods:

  • Utilized gene transfection experiments (transient and stable) to introduce novel molecular agents.
  • Quantified the downregulation of estrogen receptor (ER) expression and/or activity.

Main Results:

  • Constitutive overexpression of ER antisense RNA was highly effective in downregulating ER.
  • A dominant-negative ER mutant (DNER-1) incorporating a hormone-binding domain also demonstrated significant efficacy in reducing ER levels and activity.
  • Antisense oligonucleotides showed less efficacy compared to antisense RNA and dominant-negative mutants.

Conclusions:

  • ER antisense RNA and dominant-negative ER mutants (specifically DNER-1) are potent strategies for selective estrogen receptor downregulation.
  • These findings support the potential of these novel molecular approaches as therapeutic agents for hormone-dependent cancers.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...